Drugs / PA5108 Ocular Implant
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06964191 | May 2025 → Nov 2026 expected | ocular hypertension, open-angle glaucoma | PolyActiva Pty Ltd | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PA5108 Ocular Implant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06964191 ↗ |
| Route | Other | “Intracameral PA5108 Ocular Implants” NCT06964191 ↗ |